Comparative study of peginterferons in genotype 2 or 3 chronic hepatitis C naive patients

被引：0

作者：

Margusino Framinan, Luis ^{[1
]}

Espana Valino, Lorenley ^{[1
]}

Sanchez Batan, Sonia ^{[1
]}

Castro Iglesias, Angeles ^{[2
]}

Pertega Diaz, Sonia ^{[3
]}

Martin Herranz, Isabel ^{[1
]}

机构：

[1] Juan Canalejo, Pharm, La Coruna, Spain

[2] Juan Canalejo, Internal Med, La Coruna, Spain

[3] Juan Canalejo, Epidemiol, La Coruna, Spain

来源：

PHARMACY WORLD & SCIENCE | 2009年 / 31卷 / 02期

关键词：

Hepatitis C; Chronic; Interferons; Ribavirin; PLUS RIBAVIRIN;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：345 / 345

页数：1

共 2 条

[1] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[2] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].

Manns, MP ;

McHutchison, JG ;

Gordon, SC ;

Rustgi, VK ;

Shiffman, M ;

Reindollar, R ;

Goodman, ZD ;

Koury, K ;

Ling, MH ;

Albrecht, JK .

LANCET, 2001, 358 (9286) :958-965

← 1 →